Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Pioglitazone improves insulin resistance in NIDDM

June 12, 1997

New preclinical studies on JTT-501

June 12, 1997

Clinical results in NIDDM reported for troglitazone

June 12, 1997

Efficacy of pioglitazone demonstrated in NIDDM patients

June 11, 1997

Miglitol tested in specific population subgroups

June 11, 1997

Clinical results reported for Novo Nordisk insulinotropic agent

June 11, 1997

NN-304, a long-acting insulin analogue in preclinical testing

June 10, 1997

Skelid introduced in the U.S.

June 10, 1997

New antidiabetic agent from Japan Tobacco

June 10, 1997

Agent for gastroparesis in diabetic patients

June 10, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 30, 2026.
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Regulatory actions for July 27, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Alfasigma,...